David Matthew Friedman - 03 Feb 2026 Form 4 Insider Report for Veradermics, Inc (MANE)

Role
Director
Signature
/s/ Michael Greco, Attorney-in-Fact
Issuer symbol
MANE
Transactions as of
03 Feb 2026
Net transactions value
$0
Form type
4
Filing time
05 Feb 2026, 19:04:54 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Friedman David Matthew Director C/O VERADERMICS, INCORPORATED, 470 JAMES ST., NEW HAVEN /s/ Michael Greco, Attorney-in-Fact 05 Feb 2026 0002108980

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MANE Stock Option (Right to Buy) Award $0 +43,000 $0.000000 43,000 03 Feb 2026 Common Stock 43,000 $17.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of options to purchase shares of the Issuer's common stock awarded to Mr. Friedman in connection with his role as a member of the Issuer's Board of Directors. Mr. Friedman, as an employee of Suvretta Capital Management, LLC ("Suvretta Capital"), the investment manager of Averill Master Fund, Ltd. and Averill Madison Master Fund, Ltd (the "Funds"), is holding such options for the benefit of the Funds, and as such Mr. Friedman disclaims beneficial ownership of such options. The Funds, and Suvretta Capital may be deemed to have an indirect pecuniary interest in such options because Suvretta Capital has rights to receive the benefit of director compensation provided in respect of Mr. Friedman's board service.
F2 This option shall be fully vested and exercisable on February 3, 2027, the first anniversary of the vesting commencement date.